International Journal of Community Medicine and Public Health Thamilmanni S et al. Int J Community Med Public Health. 2021 Jul;8(7):3561-3584 http://www.ijcmph.com pISSN 2394-6032 | eISSN 2394-6040
DOI: https://dx.doi.org/10.18203/2394-6040.ijcmph20212619
Systematic Review
Role of physical activity and metabolic syndrome in determining the
risk of postmenopausal breast cancer: a systematic review
Shuwaathi Thamilmanni*, Calvin Preetivan Noris, Amuthaganesh Mathialagan, Kanakeswary Karisnan
School of Medicine, Perdana University- Royal College of Surgeons in Ireland, Malaysia Received: 25 April 2021 Revised: 06 June 2021 Accepted: 07 June 2021 *Correspondence: Shuwaathi Thamilmanni, E-mail: 18924482@perdanauniversity.edu.my Copyright: © the author(s), publisher and licensee Medip Academy. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
ABSTRACT Physical activity (PA) and metabolic syndrome (MetS) have emerged as crucial factors in facilitating the incidence of postmenopausal (PM) breast cancer (BC). The association of PA, MetS and its components with PM BC was explored in this study. PRISMA guideline was followed and online databases were searched comprehensively to find relevant cohort and case-control studies until 18 February 2021 using keywords such as “physical activity”, “metabolic syndrome” and “breast cancer”. Eligible studies evaluating BC in postmenopausal women with a clear definition and measure of PA, MetS and its individual components were selected. A total of twenty-three articles related to PA and fifteen articles for MetS met the eligibility criteria and were assessed thoroughly. PA and MetS were significantly associated with PM BC. There was evidence of dose-response effect of PA and Mets on PM BC. Obesity, diabetes and dyslipidaemia were independently associated with PM BC and posed an increased risk on PM BC whereas the association of HPTN with PM BC was not prominent. Consistent and sustained long term PA throughout one’s lifetime was observed to decrease PM BC risk whereas increasing number of MetS components increased the risk of PM BC. Routine screening for PM women with ≥2 MetS components and obese or overweight women with any of the MetS components may be beneficial in early BC detection. Lifestyle modifications with emphasis on long term PA would be beneficial to public health in preventing and improving MetS outcomes as well as a primary prevention of sporadic PM BC. Keywords: Physical activity, Metabolic syndrome, Obesity, Hypertension, Diabetes, Dyslipidaemia, Postmenopausal breast cancer
INTRODUCTION
Breast cancer (BC) is the most commonly diagnosed malignancy in females worldwide, surpassing lung cancer incidence in 2020. It represents 11.7% of all cancer cases, ranks fifth in cancer mortality and represents 1 in 4 cancers diagnosed among women globally.1 As of now, the incidence of BC in Asian women is still lower compared to western countries. However, the rate of BC incidence is expected to increase in many less developed countries due to the increased life expectancy and westernisation of their
lifestyle. The rate of premenopausal breast cancers is rising in higher-income countries, whereas the trend of postmenopausal (PM) BC is on the rise in developing, but lower-income countries.2
The pathogenesis of BC involves genetic, environmental and hormonal factors. Although BCs are typically associated with non-modifiable risk factors such as family history, age, early menarche and menstrual history, most BCs are sporadic.
International Journal of Community Medicine and Public Health | July 2021 | Vol 8 | Issue 7 Page 3561
Thamilmanni S et al. Int J Community Med Public Health. 2021 Jul;8(7):3561-3584
Physical activity
PA is defined as bodily movement via skeletal movement which generates expenditure of energy above the resting metabolic rate. It is represented by modality, frequency, intensity, duration, and context of practice.3 A study done in 2007 stated that, decreased hormone replacement therapy (HRT) usage and the substantially increased obesity rate may be attributable to physical inactivity emerging as the major modifiable risk factor for BC.4 Besides, a systematic review study found exercise to decrease PM BC risk by approximately 15%-20%.5 Several studies showed a dose-response relationship between PA and BC risk where increased frequency and duration of activity provides greater benefit.4-6
Metabolic syndrome (MetS)
MetS is characterised by a combination of biological abnormalities and clinical conditions such as altered glucose and metabolism leading to hyperglycaemia and hyperinsulinaemia, obesity, dyslipidaemia characterised by low high-density lipoprotein (HDL) cholesterol and high triglyceride level and hypertension (HPTN). Each component plays a unique role in influencing the evolution of BC. Although MetS often meets various definitions, it is often defined as having 3 or more components including: Fasting glucose ≥100 mg/dL or receiving drug therapy for hyperglycaemia, blood pressure(BP) ≥130/85 mm Hg or receiving drug therapy for HPTN, triglycerides ≥150 mg/dL or receiving drug therapy for hypertriglyceridemia, HDL-C < 40 mg/dL in men or < 50 mg/dL in women or receiving drug therapy for reduced HDL-C, waist circumference ≥102 cm (40 in) in men or ≥88 cm (35 in) in women; if Asian American, ≥90 cm (35 in) in men or ≥80 cm (32 in) in women.7
MetS is a known risk factor for cardiovascular diseases. However, recently, MetS has been linked with the pathogenesis and prognosis of various cancers. Age was also observed to impact the occurrence of MetS and BC, thus menopausal status could be the causal relationship between these conditions.8
According to the Million Women Study, the majority of cancers, 81% occurred in postmenopausal women and obesity was found to be the most attributable cause in approximately half of them.9 Many epidemiological studies have proven obesity and diabetes to be independently associated with PM BC however, the association of dyslipidaemia and HPTN especially on PM BC are still controversial.
Objective
This systematic review has explored the association of physical activity, metabolic syndrome as well as its individual components with postmenopausal breast cancer respectively.
METHODS
This study has been approved by the Perdana University Institutional Review Board (PU-IRB). This study was conducted in accordance with the Preferred Reporting Items for Systematic review and Meta-analysis (PRISMA) guidelines.11 Online databases such as PubMed, Google scholar and Embase and Cochrane Database of Systematic Reviews and Cochrane Central Register of Controlled Trials (EBCOHost) were searched comprehensively to find relevant articles until 18 February 2020. Keywords such as “physical inactivity” or “physically inactive” or “obese” or “obesity” and “metabolic syndrome” or “metabolic disorders” and “breast cancer” or “breast neoplasm” and “postmenopausal women” or “menopause” were used to form the search strategy. Manual searches were also performed to look for more eligible articles in the reference lists of the retrieved and review articles. The study title along their abstracts were imported into EndNote to remove duplicates and to screen literature.
Eligibility criteria
Inclusion criteria: The studies were considered eligible if they met the following criteria: the study design was a cohort or case-control; PA measure was clearly defined (type of activity, duration, intensity); MetS was clearly defined; BC in PM women was evaluated; only studies published in English language were included; relative risk (RR) or odds ratio (OR) or Hazard ratio (HR) with 95% confidence intervals (CIs) on the association between PA, MetS and PM BC respectively was reported.
Exclusion criteria were: non-human experiments; no clear definition of MetS; no clear definition and measure of PA; did not distinguish the menopausal status; prior diagnosis of other cancers except non-melanoma skin cancer; no recurring BC patients; if physical inactivity was measured by sedentary behaviour (lack of exercise).
Quality assessment
The quality of studies was assessed according to the Newcastle Ottawa quality assessment scale which is a validated scale for nonrandomized studies.11 Good quality was defined as a score ≥7, fair was defined as a score of 5– 6 and poor quality being score of <5.
Literature screening and data extraction
The titles and abstracts were screened based on the eligibility criteria. After removing duplicates and unrelated articles, 24 articles related to PA and 15 articles for MetS were evaluated. Then, relevant data was comprehensively extracted and tabulated in a word document which included study characteristics and summary of results of all studies assessed. The article screening process is depicted in Figure 1.
International Journal of Community Medicine and Public Health | July 2021 | Vol 8 | Issue 7 Page 3562
Thamilmanni S et al. Int J Community Med Public Health. 2021 Jul;8(7):3561-3584
Figure 1: Screening process for studies to be included in this systematic review.
RESULTS
The characteristics of the cohort studies included are summarised in Table 1. Out of 17 cohort studies included, 14 studies had a follow-up of more than 5 years, with the longest follow-up being 27 years 26 and the shortest being 4.7 years.14 The quality of all studies included assessed based on the NOS scale ranged from a minimum of 6 stars to 9 stars and for cohort studies, 15 out of 17 studies obtained 7 or more stars, indicating good quality. The characteristics of 18 case-control and 3 case-cohort studies are summarised in Table 2. Of the 20 studies, 17 were of good quality, with ≥7 stars. Most included studies considered women to have attained menopause if period had stopped ≥12 months prior to selection or diagnosis or if the cessation of menses is caused by bilateral oophorectomy or hysterectomy with removal of <2 ovaries or of older age which varied across studies. The crucial factors included and adjusted for in most studies are, age at menarche, parity, family history of BC, BMI, dietary pattern, history of breastfeeding history, use of HRT, smoking history, alcohol consumption, use of birth control, age at first pregnancy.
For studies determining the association between PA and PM BC, the measures of PA, results, summary and adjusted variables are outlined in Table 3. Data on PA was self-reported and collected via questionnaires, telephone or face-to-face interviews. Different parameters were investigated in each study such as the domain of PA and the dose of PA (frequency, duration and intensity). A total
of eleven studies investigated recreational PA, ten studies investigated total PA done throughout participants’ life until selection/diagnosis and only 7 studies investigated occupational PA(OPA) alone in PM women, out of which 5 studies yielded significant association between OPA and PM BC.13,18,23,29,33 Of the 23 studies that presented results for the association between PA and PM BC, statistically significant PM BC risk reduction was evident in 22 studies and one study produced non-statistically significant risk reduction while another did not observe strong association as only baseline PA and PM BC was significantly associated.12,28 Certain studies exhibited dose-response relationship where with increasing frequency and intensity of PA, the risk of PM BC incidence decreased.14,15,23,31,36,37,38
Some included studies found that the association between PA and PM BC is affected by HRT while some did not find any effect modification by HRT.14,16-20,28,30,32 However, some studies have shown promising results as PA reduces risk among HRT users who are particularly a high-risk group for developing PM BC.14 Besides, several included studies observed a more pronounced impact of exercise among lean women or from lower tertiles of BMI whereas some studies found greatest risk reduction among women in the higher BMI category.14,16,23,30,34,38,39 Some studies did not find any effect modification by BMI on PA.18,22,31,37 Table 4 describes the measures, results, summary and adjusted variables of all studies investigating MetS and PM BC.
International Journal of Community Medicine and Public Health | July 2021 | Vol 8 | Issue 7 Page 3563
Thamilmanni S et al. Int J Community Med Public Health. 2021 Jul;8(7):3561-3584
Table 1: Characteristics of cohort studies included.
International Journal of Community Medicine and Public Health | July 2021 | Vol 8 | Issue 7 Page 3564
Thamilmanni S et al. Int J Community Med Public Health. 2021 Jul;8(7):3561-3584
Table 2: Characteristics of Case-control studies included.
Continued.
International Journal of Community Medicine and Public Health | July 2021 | Vol 8 | Issue 7 Page 3565
Thamilmanni S et al. Int J Community Med Public Health. 2021 Jul;8(7):3561-3584
Table 3: Measure, definition, results, summary and adjusted variables of studies investigating relationship PA and PM BC.
Continued.
International Journal of Community Medicine and Public Health | July 2021 | Vol 8 | Issue 7 Page 3566
Thamilmanni S et al. Int J Community Med Public Health. 2021 Jul;8(7):3561-3584
Continued.
International Journal of Community Medicine and Public Health | July 2021 | Vol 8 | Issue 7 Page 3567
Thamilmanni S et al. Int J Community Med Public Health. 2021 Jul;8(7):3561-3584
Continued.
International Journal of Community Medicine and Public Health | July 2021 | Vol 8 | Issue 7 Page 3568
Thamilmanni S et al. Int J Community Med Public Health. 2021 Jul;8(7):3561-3584
Continued.
International Journal of Community Medicine and Public Health | July 2021 | Vol 8 | Issue 7 Page 3569
Thamilmanni S et al. Int J Community Med Public Health. 2021 Jul;8(7):3561-3584
Continued.
International Journal of Community Medicine and Public Health | July 2021 | Vol 8 | Issue 7 Page 3570
Thamilmanni S et al. Int J Community Med Public Health. 2021 Jul;8(7):3561-3584
Continued.
International Journal of Community Medicine and Public Health | July 2021 | Vol 8 | Issue 7 Page 3571
Thamilmanni S et al. Int J Community Med Public Health. 2021 Jul;8(7):3561-3584
Continued.
International Journal of Community Medicine and Public Health | July 2021 | Vol 8 | Issue 7 Page 3572
Thamilmanni S et al. Int J Community Med Public Health. 2021 Jul;8(7):3561-3584
International Journal of Community Medicine and Public Health | July 2021 | Vol 8 | Issue 7 Page 3573
Thamilmanni S et al. Int J Community Med Public Health. 2021 Jul;8(7):3561-3584
Table 4: Measure, definition, results, summary and adjusted variable of Studies investigating relationship MetS and PM BC.
Continued.
International Journal of Community Medicine and Public Health | July 2021 | Vol 8 | Issue 7 Page 3574
Thamilmanni S et al. Int J Community Med Public Health. 2021 Jul;8(7):3561-3584
Continued.
International Journal of Community Medicine and Public Health | July 2021 | Vol 8 | Issue 7 Page 3575
Thamilmanni S et al. Int J Community Med Public Health. 2021 Jul;8(7):3561-3584
Continued.
International Journal of Community Medicine and Public Health | July 2021 | Vol 8 | Issue 7 Page 3576
Thamilmanni S et al. Int J Community Med Public Health. 2021 Jul;8(7):3561-3584
Risk Estimate (95% CI) Test for Trend
Author Exposure measurement Contrast
Change in weight from age 18 to reference date (%) ≥ 29.2 % vs Negative change to no change
BMI & Adult weight change only Self-reported height and weight at age 18 years and at the reference date was recorded. BMI was estimated as weight in kilograms divided by the square of height in meters. Percent change in weight between age 18 and the reference date was calculated.
OR= 1.36 (1.08–1.73) P for trend= 0.01
Carpenter et al32
Summary Adjusted variables
Age at first full-term pregnancy, ages at menarche and menopause, family history of BC, interviewer, average MET hours per week of lifetime exercise activity
Women who experienced the greatest percent weight gain between age 18 and the reference age were at increased PM BC risk.
Table 5: Results of the association between individual components of MetS and PM BC.
Continued.
International Journal of Community Medicine and Public Health | July 2021 | Vol 8 | Issue 7 Page 3577
Thamilmanni S et al. Int J Community Med Public Health. 2021 Jul;8(7):3561-3584
.
International Journal of Community Medicine and Public Health | July 2021 | Vol 8 | Issue 7 Page 3578
Thamilmanni S et al. Int J Community Med Public Health. 2021 Jul;8(7):3561-3584
International Journal of Community Medicine and Public Health | July 2021 | Vol 8 | Issue 7 Page 3579
Thamilmanni S et al. Int J Community Med Public Health. 2021 Jul;8(7):3561-3584
Most studies had trained personnel measure the anthropometric characteristics such as weight, height, waist circumference and draw blood to analyse the serum glucose, triglyceride, HDL levels and measure BP during clinic visits and the method used was standardised for all participants accordingly in every study.
Some studies obtained self-reported history of medication used for the metabolic conditions and self-reported body weight and height. All studies included demonstrated a significant association between MetS and PM BC risk. 15 studies evaluated the role of MetS and all studies found MetS to be a significant predictor of PM BC. A dose- response relationship was evident, where increasing number of MetS components further increased the PM BC incidence. There were some studies observed effect modification by HRT on BMI or weight gain.16,25,24,44
MetS is an aggregation of multiple factors which are also standalone risk factors of BC. To overcome this limitation, we also looked into the influence of individual components of MetS. Table 5 shows the results of studies depicting the association between individual factors of MetS and PM BC. In relation to PM BC, seven out of ten studies produced significant association for BMI, 2 out of 7 studies showed significant association for high waist circumference, 6 out of 10 studies showed significant association for diabetes, 5 out of 11 studies demonstrated significant association for dyslipidaemia and 4 out of 10 studies showed significant association for hypertension. Obesity and diabetes posed the highest risk of PM BC of all the other individual MetS components. There were few studies which showed significant association between high BP and PM BC, however the results were inconsistent.
DISCUSSION
In this systematic review, the key observational epidemiologic studies examining the impact of PA and MetS and its components, obesity, HPTN, T2DM and dyslipidaemia on PM BC independently have been qualitatively studied and the results outlined. This study has demonstrated a very strong inverse association between PA and PM BC. Similarly, an inverse association between PA and PM BC was evident in a 2007 systematic review which produced PM BC risk reductions ranging from 20-80%.5 This hypothesis is also in line with many epidemiological studies further strengthening this association.4,6 A possible linear dose-response relationship was observed in this study and of note, one study demonstrated a non-linear dose response relation where significant PM BC risk reduction was observed when moderate-intensity recreational PA increased up to 16 METs-hour/week but higher intensity of PA exceeding 16 METs-hr/wk was not associated with decreased risk.37
The impact of PA varies depending on its domains, duration and intensity. In particular, recreational PA domain was the most prominent in PM BC risk reduction. A study that investigated occupational and household PA
showed a significant association with 38% risk reduction for invasive BC in women who were engaged in heavy lifting or carrying routinely at home or work.18
Future researches should explore more on OPA and transport related PA domains as there are not many studies available on this currently although the in this era, PA related to occupation and transportation may not be as effective in contributing to PM BC risk reduction as people are mostly chairbound in their workplace and commute using public transport or motor vehicles. The exact period in life which was most important to be physically active could not be distinguished from this study. One of the studies included demonstrated PM BC risk reduction among women who maintained an average of 17.6 MET- hour of activity per week starting from their menarche.32 Another study stated that greatest reduction in risk of PM BC was associated with frequent early life PA in those who either lost weight or gained modest amount of weight over their adult life.30 From the existing evidence, the key to having the greatest risk reduction of PM BC may be engaging in sustained, moderate-intensity PA from menarche onwards throughout one’s lifetime. Exercising during childhood and adolescence may be beneficial as exercise is proven to reduce fat storage and exposure to sex hormones, delaying menarche and increased anovulation while exercising after menopause may be helpful in reducing weight gain which in turn decreases the risk of PM BC.29 Another study observed BC risk reduction in those who exercise at or above the recommended level (8 MET hr/wk/yr).23 Also, just walking for an hour per day and engaging in weekly exercises seemed to be efficacious against PM BC.22
BMI was observed to attenuate the effect of PA on PM BC in several studies however the results did not consistently show a differential effect of PA on high or low BMI groups. On the contrary, another systematic review stated that BMI does not modify the effect of PA on PM BC risk.5 Hence, it is unclear if the lack of association in among high or low BMI women is due to lesser number of women with the required PA level or if the independent impact of PA is overshadowed by excessive adiposity. One of the studies included observed a significant PM BC risk reduction of 56% being further reduced to 68% after multivariate adjustment, in which BMI and parity were mainly responsible.35 The accumulating evidence that PM BC risk is increased by higher body fat distribution is insufficient in confirming this hypothesis as the relation between PA and body fat distribution is scarcely studied. Future researches on the associations between PA, (including recreational, occupational, household, transport related sources), BMI and distribution of body fat may be enlightening in terms of the mechanisms underlying the impact of PA on PM BC risk.
The PM BC risk could be lowered by long term PA via the pathways of estrone, BMI, insulin resistance, and C- reactive protein, with estrone and BMI most convincingly associated with PA and PM BC risk. PA in general is said
International Journal of Community Medicine and Public Health | July 2021 | Vol 8 | Issue 7 Page 3580
Thamilmanni S et al. Int J Community Med Public Health. 2021 Jul;8(7):3561-3584
to reduce the higher circulating level of oestrogen and androgen in PM women and enhance immune surveillance by modulating immune responses in circulation as well as alter the immune landscape within the tumour microenvironment leading to better infiltration of effector cells and reduced immunosuppression.48 Importantly, PA after menopause is specifically associated with suppressed level of sex hormones or increased insulin sensitivity. Studies have proven that decreased BMI further decreases insulin and insulin resistance after engaging in physical exercises.21 The consensus is, women who were engaged in at least recommended or moderate level of PA regularly or had an active lifestyle overall and maintained a normal adult body weight had the greatest PM BC risk reduction. A major limitation in the included studies is, the information on minimal dose of PA necessary to cause an impact on the risk of PM BC was lacking. Also, different intensities of recreational PA may have different dose- response effect with PM BC risk. In that case, it is safe to conclude that recommended level or consistent moderate intensity PA is sufficient to induce PM BC risk reduction. These results are promising as engaging in the most strenuous activities are not necessarily required to reduce the risk of PM BC.
The jury is still out on the debate whether MetS is a real syndrome or a cluster of unrelated phenotypes. Nonetheless, MetS fulfils the criteria of a syndrome which means aggregation of factors which occur together more often than by chance alone and for which the reason is uncertain.7 In this study, MetS was significantly associated with PM BC and a linear association was observed suggesting that multiple molecular pathways underlying MetS are activated which may contribute to breast tumorigenesis. The results produced by this study is supported by another meta-analysis which showed a two- fold increase in BC risk among PM MetS and a few other studies which reported a significant association between MetS and PM BC with increasing number of MetS components, the risk of PM BC was markedly increased.7,8,49
A few mechanisms namely, increased visceral adiposity, android fat distribution, hyperinsulinemia, chronic inflammation and free androgen are the suggested pathogenesis by which MetS per se leads to breast carcinogenesis.41 Importantly, the presence of other metabolic factors together with obesity posed a higher risk of PM BC.25,43,44,47 Obesity, represented by high BMI and diabetes emerged as the most significant effect modifier followed by dyslipidaemia and HPTN. This study proves that obesity when combined with diabetes and dyslipidaemia posed the greatest risk of PM BC, emerging as the most lethal combination of biological abnormality. This gives rise to a new perspective to consider in regards to prevention of PM BC incidence. A large prospective cohort study demonstrated obese women who are metabolically unhealthy had the highest PM BC risk and despite metabolic health, obesity increased the risk of PM BC.25 High BMI, dyslipidaemia and diabetes demonstrated
an independent association with PM BC. On the contrary to this result, several studies stated that none of the individual MetS components were strong enough to be considered responsible for breast carcinogenesis alone.41,44
Besides BMI, other indicators of adiposity, such as waist circumference, waist-to-hip ratio and adult weight gain have been also deemed as probable risk factors of PM BC risk because accumulation of visceral adipose tissue in PM women is related to the alteration of the concentration and availability of sex hormones after menopause.6,28,32,40 In contrast, a study done in the Canadian study of diet, lifestyle and health cohort showed no evidence between PM BC with increasing BMI, but adult weight gain was found to be strongly associated with PM BC risk which estimated a 6% increase in PM BC risk with every 5 kg gained since age 20 independent of the use of HRT.28
The most plausible mechanism linking MetS to PM BC is hormone-related, particularly insulin, which is why MetS is also called as the insulin resistance syndrome. The molecular mechanism underlying all MetS components are somehow interlinked. The main contributing factor to the progression of insulin resistance is the excessive amount of circulation fatty acid released from adipose tissue. The insulin resistance provides a conceptual framework which relates a number of otherwise unrelated pathophysiological pathways as it acts as a chain reaction which leads to the occurrence of consequent biological mechanisms. Insulin is the main hormone involved in stimulating cell proliferation hence it directly promotes the growth of breast tissue and tumour cells, leading to BC incidence. Insulin upregulates insulin-like growth factor (IGF) levels acting as mitogens.48 Another vital factor, the adiponectin (adipocyte-associated protein) aids with the metabolism of fatty acid and glucose metabolism as well as insulin sensitivity and resistance. In obese patients, adiponectin level is substantially reduced, which gives a suitable medium for tumour angiogenesis.49
The oestrogen levels in adipose tissue of obese PM women are generally high after menopause as the ovarian oestrogen production decreases and adipose tissue becomes the major source of oestrogen due to androgen aromatization in peripheral adipose tissue into estradiol. Obesity facilitates this process, increasing estradiol which decreases production of adiponectin and thereby weakening the antitumour effect of adiponectin. On the other hand, there is sex hormone binding globulin (SHBG) which is a glycoprotein synthesised by liver which binds and transports active forms of oestrogens and androgens in blood.49 In cases of hyperinsulinemia, increased IGF and obesity, SHBG synthesis is decreased which results in increased circulating bioavailable oestrogens, subsequently prompting a vicious cycle. This mediating role of oestrogen is supported from observations that the association between BMI and PM BC was essentially eliminated after adjustment for bioavailable oestrogen concentration.48 Besides, the substantially weakened association with BMI in HRT users also indicates that this
International Journal of Community Medicine and Public Health | July 2021 | Vol 8 | Issue 7 Page 3581
Thamilmanni S et al. Int J Community Med Public Health. 2021 Jul;8(7):3561-3584
exogenous hormone source overrides the effect of endogenous oestrogen production from peripheral fat tissue. This study also corroborates this finding where HRT was found to exert some modification on the association of BMI with PM BC. More exploration is needed to identify how HRT comes into play in regards to its effect on the association between, PA, BMI and weight gain with PM BC.
In this review, the studies included showed a significant association between T2DM and PM BC. However, there might be possible residual confounding by overweight/obesity as the insulin resistance caused by obesity may give rise to diabetes due to their common pathophysiological pathway. A meta-analysis has demonstrated a 20% increase in BC risk compared to women without diabetes.50 The effect of insulin resistance seemed more marked in PM women. To strengthen this observation, PM women with T2DM were 17% more likely to get BC than women without diabetes in the Nurses’ Health Study even after controlling for all the confounding variables.
The association between HPTN and PM BC has been long investigated, yet with inconsistent results. A cohort study which investigated HPTN only concluded that PM BC incidence in general, does not vary from that of the general population however, elevated DBP levels may be associated with an increased BC risk among non- pharmacologically treated women. Besides the common pathophysiological pathway, it shares with other MetS factors, another possible explanation is that HPTN may increase BC risk by blocking and subsequently modifying apoptosis, thereby affecting the regulation of cell turnover.26
Age is an integral factor in pathogenesis of BC as the transition from premenopausal to postmenopausal constitutes a window where there is hormonal imbalance which favour the initiation of breast tumorigenesis.6 Thus far, BMI and sex hormones are the most commonly cited biomarkers associating PA and reduced risk of PM BC, however emerging studies propose insulin resistance and chronic inflammation could be pivotal too as several mechanisms act simultaneously in increasing the incidence of PM BC.
There were a few limitations in this review. Firstly, the heterogeneity among studies was unavoidable although subgroup analysis was conducted because the measures of the MetS factors and PA varied across studies making interpretation challenging. Only observational studies can be conducted to evaluate the association between PA, MetS and its factors with PM BC respectively. Thus, only cohort and cross-sectional studies were included. Moreover, recall bias was possible because the data from recalling PA done in early adulthood and their body weight might have been inaccurate. The strengths of this review are, a wide range of studies with a large scale of
participants and long follow up years were included. Most of the studies included were of high quality.
CONCLUSION
In summary, it is evident that PA and MetS are significantly associated with postmenopausal breast cancer. Regular PA of moderate intensity or recommended level of PA while maintaining a normal BMI from menarche onwards may be helpful in lowering PM BC risk whereas having ≥3 factors of MetS increases the risk of PM BC. This systematic review has shown obesity, diabetes and dyslipidaemia to pose an increased risk on PM BC whereas the association of HPTN and PM BC was weak. Routine BC screening could help detect BC in its early stages for PM women with MetS or overweight or obese women with other MetS components. As opposed to menopausal status, age or genetic background, obesity is a preventable and reversible modifiable risk factor hence, specific interventions to reduce obesity and adult weight gain as well as promoting sustained PA would be beneficial in curbing MetS and decreasing the risk of PM BC. Mechanistic insight underpinning the definite molecular and biological pathways by which long-term PA contribute to the risk of PM BC to highlight the existing epidemiologic gaps are needed to confirm the causal relationship between these factors. This would also create awareness among public about the health benefits of PA in reducing the risk of BC in a postmenopausal woman and for medical practitioners to prescribe PA as a critically crucial regimen extending beyond improving outcomes of MetS and also in reducing the risk of PM BC.
ACKNOWLEDGEMENTS
We would like to extend our gratitude to the authors and participants of the studies included in this systematic review for their valuable contribution.
Funding: No funding sources Conflict of interest: None declared Ethical approval: Not required
REFERENCES
1. GLOBOCAN 2020: New Global Cancer Data. UICC. 2020. Available at: https://www.uicc.org/news/ globocan-2020-new-global-cancer-data. Accessed on 21st February 2021. 2. Global Incidence of Premenopausal, Postmenopausal Breast Cancer Rising. AJMC. Available at: https://www.ajmc.com/view/global-incidence-of- premenopausal-postmenopausal-breast-cancer- rising. Accessed on 22nd February 2021. 3. Thivel D, Tremblay A, Genin PM, Panahi S, Rivière D, Duclos M. Physical Activity, Inactivity, and Sedentary Behaviors: Definitions and Implications in Occupational Health. Frontiers in Public Health. 2018;6.
International Journal of Community Medicine and Public Health | July 2021 | Vol 8 | Issue 7 Page 3582
Thamilmanni S et al. Int J Community Med Public Health. 2021 Jul;8(7):3561-3584
4. Bernstein L. Exercise and breast cancer prevention. Current Oncology Reports. 2009;11(6):490-6. 5. Monninkhof EM, Elias SG, Vlems FA. Physical activity and breast cancer: a systematic review. Epidemiology 2007;18(1):137-57. 6. Adraskela K, Veisaki E, Koutsilieris M, Philippou A. Physical Exercise Positively Influences Breast Cancer Evolution. Clinical Breast Cancer. 2017;17(6):408-17. 7. Alberti K, Eckel R, Grundy S, Zimmet P, Cleeman J, Donato K et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Forceon Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Obesity and metabolism. 2010;7(1):63-5. 8. Kabat GC, Kim M, Chlebowski RT, Khandekar J, Ko MG, McTiernan A, et al. A longitudinal study of the metabolic syndrome and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev. 2009;18(7):2046-53. 9. Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D. Cancer incidence and mortality in relation to body mass index in the Million Women Study: Cohort study. Br Med J. 2007;335(7630):1134-9. 10. Kamioka H. Preferred reporting items for systematic review and meta-analysis protocols (prisma-p) 2015 statement. Japanese Pharmacol Ther. 2019;47(8):1177-85. 11. Ottawa Hospital Research Institute. Ohri.ca. 2021. http://www.ohri.ca/programs/clinical_epidemiology/ oxford.asp. Accessed on 20th February 2021. 12. Rosenberg L, Palmer JR, Bethea TN, Ban Y, Kipping-Ruane K, Adams-Campbell LL. A prospective study of physical activity and breast cancer incidence in African-American women. Cancer Epidemiol Biomarkers Prev. 2014;23(11):2522-31. 13. Ekenga CC, Parks CG, Sandler DP. A prospective study of occupational physical activity and breast cancer risk. Cancer Causes Control. 2015;26(12):1779-89. 14. McTiernan A, Kooperberg C, White E, Vogel VG. Recreational physical activity and the risk of breast cancer in postmenopausal women: The women’s health initiative cohort study. Breast Dis. 2004;15(1):25-6. 15. Bardia A, Hartmann LC, Vachon CM, Vierkant RA, Wang AH, Olson JE, et al. Recreational physical activity and risk of postmenopausal breast cancer based on hormone receptor status. Arch Intern Med. 2006;166(22):2478-83. 16. Chang SC, Ziegler RG, Dunn B, Stolzenberg- Solomon R, Lacey J V, Huang WY, et al. Association of energy intake and energy balance with postmenopausal breast cancer in the prostate, lung,
colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev. 2006;15(2):334-41. 17. Patel A V, Calle EE, Bernstein L, Wu AH, Thun MJ. Recreational physical activity and risk of postmenopausal breast cancer in a large cohort of US women. Cancer Causes Control. 2003;14(6):519-29. 18. George SM, Irwin ML, Matthews CE, Mayne ST, Gail MH, Moore SC, et al. Beyond recreational physical activity: Examining occupational and household activity, transportation activity, and sedentary behavior in relation to postmenopausal breast cancer risk. Am J Public Health. 2010;100(11):2288-95. 19. Eliassen A, Hankinson S, Rosner B, Holmes M, Willett W. Physical Activity and Risk of Breast Cancer Among Postmenopausal Women. Archives of Internal Medicine. 2010;170(19). 20. Howard RA, Leitzmann MF, Linet MS, Freedman DM. Physical activity and breast cancer risk among pre- and postmenopausal women in the U.S. Radiologic Technologists cohort. Cancer Causes Control. 2009;20(3):323-33. 21. Suzuki S, Kojima M, Tokudome S, Mori M, Sakauchi F, Fujino Y, et al. Effect of physical activity on breast cancer risk: Findings of the Japan collaborative cohort study. Cancer Epidemiol Biomarkers Prev. 2008;17(12):3396-401. 22. Pronk A, Ji BT, Shu XO, Chow WH, Xue S, Yang G, et al. Physical activity and breast cancer risk in Chinese women. Br J Cancer. 2011;105(9):1443-50. 23. Osaki Y, Taniguchi S, Tahara A, Okamoto M, Kishimoto T. Metabolic syndrome and incidence of liver and breast cancers in Japan. Cancer Epidemiol. 2012;36(2):141-7. 24. Bosco JLF, Palmer JR, Boggs DA, Hatch EE, Rosenberg L. Cardiometabolic factors and breast cancer risk in U.S. black women. Breast Cancer Res Treat. 2012;134(3):1247-56. 25. Kabat GC, Kim MY, Lee JS, Ho GY, Going SB, Beebe-Dimmer J, et al. Metabolic obesity phenotypes and risk of breast cancer in postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2017;26(12):1730-5. 26. Lindgren A, Pukkala E, Tuomilehto J, Nissinen A. Incidence of breast cancer among postmenopausal, hypertensive women. Int J Cancer. 2007;121(3):641- 4. 27. Reeves KW, McLaughlin V, Fredman L, Ensrud K, Cauley JA. Components of metabolic syndrome and risk of breast cancer by prognostic features in the study of osteoporotic fractures cohort. Cancer Causes Control. 2012;23(8):1241-51. 28. Catsburg C, Kirsh VA, Soskolne CL, Kreiger N, Bruce E, Ho T, et al. Associations between anthropometric characteristics, physical activity, and breast cancer risk in a Canadian cohort. Breast Cancer Res Treat. 2014;145(2):545-52. 29. Friedenreich CM, Courneya KS, Bryant HE. Influence of physical activity in different age and life
International Journal of Community Medicine and Public Health | July 2021 | Vol 8 | Issue 7 Page 3583
Thamilmanni S et al. Int J Community Med Public Health. 2021 Jul;8(7):3561-3584
periods on the risk of breast cancer. Epidemiology. 2001;12(6):604-12. 30. Shoff SM, Newcomb PA, Trentham-Dietz A, Remington PL, Mittendorf R, Greenberg ER, et al. Early-life physical activity and postmenopausal breast cancer: Effect of body size and weight change. Cancer Epidemiol Biomarkers Prev. 2000;9(6):591- 5. 31. John EM, Horn-Ross PL, Koo J. Lifetime Physical Activity and Breast Cancer Risk in a Multiethnic Population: The San Francisco Bay Area Breast Cancer. Cancer Epidemiol Biomarkers Prev. 2003;12(11 II):1143-52. 32. Carpenter CL, Ross RK, Paganini-Hill A, Bernstein L. Effect of family history, obesity and exercise on breast cancer risk among postmenopausal women. Int J Cancer. 2003;106(1):96-102. 33. Dorn J, Vena J, Brasure J, Freudenheim J, Graham S. Lifetime physical activity and breast cancer risk in pre- and postmenopausal women. Med Sci Sports Exerc. 2003;35(2):278-85. 34. Hirose K, Hamajima N, Takezaki T, Miura S, Tajima K. Physical exercise reduces risk of breast cancer in Japanese women. Cancer Sci. 2003;94(2):193-9. 35. Awatef M, Olfa G, Rim C, Asma K, Kacem M, Makram H, et al. Physical activity reduces breast cancer risk: A case-control study in Tunisia. Cancer Epidemiol. 2011;35(6):540-4. 36. Gilliland FD, Li YF, Baumgartner K, Crumley D, Samet JM. Physical activity and breast cancer risk in hispanic and non-hispanic white women. Am J Epidemiol. 2001;154(5):442-50. 37. Si S, Boyle T, Heyworth J, Glass DC, Saunders C, Fritschi L. Lifetime physical activity and risk of breast cancer in pre-and post-menopausal women. Breast Cancer Res Treat. 2015;152(2):449-62. 38. Yang D, Bernstein L, Wu AH. Physical activity and breast cancer risk among Asian-American women in Los Angeles: A case-control study. Cancer. 2003;97(10):2565-75. 39. Dirx MJM, Voorrips LE, Alexandra Goldbohm R, Van Den Brandt PA. Baseline recreational physical activity, history of sports participation, and postmenopausal breast carcinoma risk in The Netherlands Cohort Study. Cancer. 2001;92(6):1638- 49. 40. Rosato V, Bosetti C, Talamini R, Levi F, Montella M, Giacosa A, et al. Metabolic syndrome and the risk of breast cancer in postmenopausal women. Ann Oncol. 2011;22(12):2687-92.
41. Capasso I, Esposito E, Pentimalli F, Crispo A, Montella M, Grimaldi M, et al. Metabolic syndrome affects breast-cancer risk in postmenopausal women: National Cancer Institute of Naples experience. Cancer Biol Ther. 2010;10(12):1240-3. 42. Wu AH, Vigen C, Butler LM, Tseng CC. Metabolic conditions and breast cancer risk among Los Angeles County Filipina Americans compared with Chinese and Japanese Americans. Int J Cancer. 2017;141(12):2450-61. 43. Wang M, Cheng N, Zheng S, Wang D, Hu X, Ren X, et al. Metabolic syndrome and the risk of breast cancer among postmenopausal women in north-west China. Climacteric. 2015;18(6):852-8. 44. Noh HM, Song YM, Park JH, Kim BK, Choi YH. Metabolic factors and breast cancer risk in Korean women. Cancer Causes Control. 2013;24(6):1061-8. 45. Agnoli C, Grioni S, Sieri S, Sacerdote C, Ricceri F, Tumino R, et al. Metabolic syndrome and breast cancer risk: A case-cohort study nested in a multicentre Italian cohort. PLoS One. 2015;10(6):1- 12. 46. Agnoli C, Berrino F, Abagnato CA, Muti P, Panico S, Crosignani P, et al. Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: A nested case-control study. Nutr Metab Cardiovasc Dis. 2010;20(1):41-8. 47. Ronco AL, De Stéfani E, Deneo-Pellegrini H, Quarneti A. Diabetes, overweight and risk of postmenopausal breast cancer: A case-control study in Uruguay. Asian Pacific J Cancer Prev. 2012;13(1):139-46. 48. Xu Y, Rogers C. Physical Activity and Breast Cancer Prevention: Possible Role of Immune Mediators. Frontiers in Nutrition. 2020;7. 49. Zhao P, Xia N, Zhang H, Deng T. The Metabolic Syndrome Is a Risk Factor for Breast Cancer: A Systematic Review and Meta-Analysis. Obes Facts. 2020;13(4):384-96. 50. Larsson SC, Mantzoros CS, Wolk A. Diabetes mellitus and risk of breast cancer: A meta-analysis. Int J Cancer. 2007;121(4):856-62.
Cite this article as: Thamilmanni S, Noris CP, Mathialagan A, Karisnan K. Role of physical activity and metabolic syndrome in determining the risk of postmenopausal breast cancer: a systematic review. Int J Community Med Public Health 2021;8:3561-84.
International Journal of Community Medicine and Public Health | July 2021 | Vol 8 | Issue 7 Page 3584